Blackbaud vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Blackbaud

LeaderNonprofit, Association & Government Software

Nonprofit Cloud Suite

Nonprofit cloud software suite for fundraising, financial management, and grantmaking. Charleston SC. Publicly traded (BLKB). Serves 45,000+ organizations.

About

Blackbaud is the leading cloud software company serving the nonprofit, education, and social good sectors. Headquartered in Charleston, South Carolina, and publicly traded on NASDAQ under the ticker BLKB, Blackbaud's portfolio spans fundraising CRM (Raiser's Edge NXT), financial management (Financial Edge NXT), grant management, education administration, and constituent engagement tools. The company serves approximately 45,000 organizations in 100+ countries, making it the dominant incumbent in enterprise nonprofit software.\n\nBlackbaud's flagship products have historically been the de facto standard for large nonprofits, universities, and healthcare foundations. The company has steadily migrated its product portfolio from on-premise systems to its Blackbaud SKY cloud platform, which underpins modern APIs and mobile-responsive interfaces. Its acquisition strategy has brought in ticketing (Altru), online giving (Luminate Online), and K-12 administration (Blackbaud Education Management) capabilities.\n\nAs a public company with hundreds of millions in annual recurring revenue, Blackbaud occupies a unique position in the nonprofit software market — it is large enough to serve the most complex enterprise requirements but faces growing competition from modern cloud-native challengers like Bloomerang and Bonterra targeting its mid-market flank. The company's scale, compliance certifications, and integrations with major financial and advancement platforms remain its core moats.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.